Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy

被引:0
|
作者
Li Zhuo
Nianrong Zhang
Guming Zou
Dapeng Chen
Wenge Li
机构
[1] China–Japan Friendship Hospital,Department of Nephrology
来源
Frontiers of Medicine | 2017年 / 11卷
关键词
diabetic nephropathy; clinical characteristics; renal biopsy; outcomes;
D O I
暂无
中图分类号
学科分类号
摘要
Kidney damage is common in patients with diabetes mellitus (DM). However, whether the type of kidney damage can be reliably diagnosed using clinical data alone remains unclear. Predictive factors for diabetic nephropathy (DN) outcomes are also poorly understood. In this study, the clinical manifestations of 111 cases of biopsy-proven DN were described, and the clinical and pathological parameters of patients with different DN outcomes were compared. Results showed that long DM duration ( > 10 years in 32.4% of patients), severe proteinuria (62.2%), and renal dysfunction (estimated glomerular filtration rate [eGFR] < 60 mL/(min$1.73 m2)) (52.3%) did not accurately indicate whether the condition of these patients progressed to DN. Hematuria (48.6%) failed to specify either DN or nondiabetic renal disease. Diabetic retinopathy (78.4%) was a crucial complication in patients with DN. Kaplan–Meier analysis revealed that the renal survival of 53 patients who were diagnosed with DN and were followed up was not significantly associated with glomerular classification (P > 0.05). Cox’s regression analysis demonstrated that renal survival time was significantly influenced by sex (β = 1.394, P = 0.038), hematuria (β = 0.036, P = 0.029), and eGFR (β =–0.039, P = 0.002) but was not significantly affected by age, 24 h urinary protein excretion, or glomerular classification (P > 0.05). In conclusion, the clinical characteristics of DN vary, and renal biopsy is necessary to determine renal damage patterns. Sex, hematuria, and the eGFR may affect DN outcomes, whereas the glomerular classification may not.
引用
下载
收藏
页码:386 / 392
页数:6
相关论文
共 50 条
  • [21] Long-term Clinical Outcomes of First and Second Kidney Transplantation in Patients With Biopsy-Proven IgA Nephropathy
    Kim, Y.
    Yeo, S. M.
    Kang, S. S.
    Park, W. Y.
    Jin, K.
    Park, S. B.
    Park, U. J.
    Kim, H. T.
    Han, S.
    TRANSPLANTATION PROCEEDINGS, 2017, 49 (05) : 992 - 996
  • [22] CLINICAL DIFFERENCES BETWEEN DIABETIC PATIENTS WITH BIOPSY PROVEN DIABETIC NEPHROPATHY AND DIABETIC PATIENTS WITH NON DIABETIC NEPHROPATHY
    Garcia Carro, Clara
    Irene, Agraz
    Soler Romeo, Maria Jose
    Azancot, Maria A.
    Ramos, Natalia
    Espinel, Eugenia
    Seron, Daniel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [23] Outcomes of Patients With Biopsy-Proven Sclerosing Mesenteritis
    Shah, Mihir M.
    Stackhouse, Kathryn
    Miller, Jacob A.
    Li, Yumeng
    Chalikonda, Sricharan
    GASTROENTEROLOGY, 2014, 146 (05) : S1071 - S1071
  • [24] Clinical Response to Intestine-targeted Steroid Therapy in Biopsy-proven Immunoglobulin A Nephropathy
    Lingaraj, Umesh
    Mallapur, Sashikanth
    Viswanathan, Akila
    Vankalakunti, Mahesha
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2022, 33 (06) : 755 - 760
  • [25] Clinical and morphological characteristics of biopsy-proven kidney graft rejection in Latvia
    Muizniece, Ieva
    Kuzema, Viktorija
    Ziedina, Ieva
    Petersons, Aivars
    Jusinskis, Janis
    Folkmane, Inese
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2657 - I2657
  • [26] Severe 25-Hydroxyvitamin D Deficiency May Predict Poor Renal Outcomes in Patients With Biopsy-Proven Diabetic Nephropathy
    Zhou, Ting
    Shen, Li
    Li, Ze
    Jia, Junjie
    Xing, Haifan
    Wang, Niansong
    Jiao, Qiong
    Fan, Ying
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [27] CLINICAL PROFILE OF BIOPSY-PROVEN IDIOPATHIC MYOCARDITIS
    RAMAMURTHY, S
    TALWAR, KK
    GOSWAMI, KC
    SHRIVASTAVA, S
    CHOPRA, P
    BROOR, S
    MALHOTRA, A
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1993, 41 (03) : 225 - 232
  • [28] RECURRENT BILATERAL PLEURAL EFFUSION RESPONDING TO ORAL STEROID IN A PATIENT WITH BIOPSY-PROVEN DIABETIC NEPHROPATHY: A FLAG TO PROMPT BIOPSY
    Chowdhury, Tutul
    Dolkar, Tsering
    Adhikari, Samaj
    Shrivastava, Devendra
    Mustafa, Fareeza
    CHEST, 2023, 164 (04) : 4665A - 4666A
  • [29] Clinical Outcomes in biopsy-proven NAFLD patients from the HEPAmet Spanish Registry
    Ampuero, J.
    Aller, R.
    Gallego-Duran, R.
    Banales, J.
    Crespo, J.
    Mora-Cuadrado, N.
    Garcia-Monzon, C.
    Pareja, M. J.
    Vilar-Gomez, E.
    Jimenez-Aguero, R.
    Caballeria, J.
    Loste, M. T. A.
    Escudero-Garcia, D.
    Gomez-Camarero, J.
    Panero, J. L. C.
    De Luis Roman, D. A.
    Gonzalez-Rodriguez, A.
    Latorre, M.
    Albillos, A.
    Aguilar-Urbano, V.
    Salmeron, J.
    Olcoz-Goni, J. L.
    Aspichueta, P.
    Santos-Laso, A.
    Iacono, O. L.
    Iruzubieta, P.
    Graupera, I.
    Garcia-Torres, M.
    Badia-Aranda, E.
    Guerra, J. A.
    Frances, R.
    Pastor, H.
    Pozo-Maroto, E. D.
    Diago, M.
    Martin-Mateos, R.
    Benlloch, S.
    Fernandez-Rodriguez, C.
    Rey, F. J. G. -S.
    Estevez, P.
    Andrade, R. J.
    Turnes, J.
    Romero-Gomez, Manuel
    JOURNAL OF HEPATOLOGY, 2018, 68 : S833 - S833
  • [30] Alterations of gut microbiota in biopsy-proven diabetic nephropathy and a long history of diabetes without kidney damage
    Lu, Xiao
    Ma, Junjun
    Li, Rongshan
    SCIENTIFIC REPORTS, 2023, 13 (01)